TheracosBio

Recent Finacing

Funding Round

Recent Raise

Undisclosed

TheracosBio is a Marlborough-based biopharmaceutical company developing novel therapeutics, including the FDA-approved SGLT2 inhibitor Brenzavvy (bexagliflozin).

Massachusetts, United States

1-10

Private

theracosbio.com